Date | Company | Who recommends | Recommendation | Target price |
---|---|---|---|---|
Waters Corporation | BofA/Merrill | Buy | 140 | |
UnitedHealth Group Incorporated | Morgan Stanley | Buy | 140 | |
Thermo Fisher Scientific, Inc. | Argus | Buy | 145 | |
Universal Health Services Inc. | Barclays | Buy | 150 | |
Vertex Pharmaceuticals Incorporated | Argus | Buy | 155 | |
Celgene Corporation | UBS | Buy | 156 | |
Cigna Corp. | Barclays | Buy | 156 | |
Edwards Lifesciences Corp. | RBC Capital Mkts | Buy | 160 | |
Aetna Inc. | BofA/Merrill | Buy | 162 | |
Becton, Dickinson and Company | Deutsche Bank | Buy | 167 | |
Amgen Inc. | Deutsche Bank | Buy | 180 | |
Anthem, Inc. | RBC Capital Mkts | Buy | 198 | |
Humana Inc. | Barclays | Buy | 223 | |
Alexion Pharmaceuticals, Inc. | UBS | Buy | 223 | |
Allergan plc | Deutsche Bank | Buy | 342 | |
Biogen Inc. | Bernstein | Buy | 360 | |
Regeneron Pharmaceuticals, Inc. | Barclays | Buy | 593 | |
Intuitive Surgical, Inc. | Barclays | Buy | 625 |